WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes? (WILLOW CCS)

Clinical Trial ID NCT04990791

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04990791

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.	Eur Heart J	2013	9.54
2	Regression models for prognostic prediction: advantages, problems, and suggested solutions.	Cancer Treat Rep	1985	2.76
3	Aspirin as an antiplatelet drug.	N Engl J Med	1994	2.72
4	Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.	N Engl J Med	2017	2.04
5	Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.	N Engl J Med	2017	1.72
6	Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system.	Arterioscler Thromb Vasc Biol	2009	0.93
7	Performance evaluation of the Sysmex XS-1000i automated haematology analyser.	Int J Lab Hematol	2009	0.84
8	Endothelial dysfunction in young healthy men is associated with aspirin resistance.	Vascul Pharmacol	2015	0.81
9	Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk.	J Thromb Haemost	2012	0.77
10	Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model.	Arterioscler Thromb Vasc Biol	2015	0.76
11	Evaluation of an improved immunoturbidimetic assay for serum C-reactive protein on a COBAS INTEGRA 400 Analyzer.	Clin Lab	2002	0.76
12	Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers.	Platelets	2012	0.75
13	A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia.	Thromb Haemost	2017	0.75
14	Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis.	J Am Coll Cardiol	2017	0.75